Cocrystal Pharma CEO Offers Look at Clinical Development and 2024 Value Catalysts
The company has a market cap of $15.53 million and has been trading for the last month at the lower end of its 52-week range ($3.28 - $1.32).
The company has a market cap of $15.53 million and has been trading for the last month at the lower end of its 52-week range ($3.28 - $1.32).
Monument is focused on investments in North American businesses with EBITDA of $2-$8 million.
Six companies are on the calendar through March 21.
The accused was order to pay $1,044,252, with prejudgment interest of $100,748.
Stay informed on the latest weekly Microcap news.
Sponsored content, this is a paid promotion
Comments and opinions presented in DealFlow Events publications such as The Microcap Newsletter are solely those of the analysts, corporate executives, and others quoted. They do not represent the opinions of DealFlow Events and DealFlow Events makes no recommendations on whether to buy, sell or hold shares of any particular stock. Investors are advised to conduct their own research before making an investment decision. Neither DealFlow Events nor any of its affiliates hold any position in the stocks mentioned in The Microcap Newsletter.
© DealFlow Financial Products, Inc. (d/b/a DealFlow Events). All rights reserved. DealFlow Events™ and The Microcap Conference™ and The Microcap Newsletter™ are trademarks of DealFlow Financial Products, Inc.